BR0314883A - Derivados de piridoindolona substituìdos em -3 por uma fenila, seu preparo e sua aplicação em terapêutica - Google Patents

Derivados de piridoindolona substituìdos em -3 por uma fenila, seu preparo e sua aplicação em terapêutica

Info

Publication number
BR0314883A
BR0314883A BR0314883-1A BR0314883A BR0314883A BR 0314883 A BR0314883 A BR 0314883A BR 0314883 A BR0314883 A BR 0314883A BR 0314883 A BR0314883 A BR 0314883A
Authority
BR
Brazil
Prior art keywords
group
phenyl
alkyl
preparation
conr
Prior art date
Application number
BR0314883-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Bernard Bourrie
Pierre Casellas
Paola Ciapetti
Jean-Marie Derocq
Samir Jegham
Yvette Muneaux
Camille-Georges Wermuth
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of BR0314883A publication Critical patent/BR0314883A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0314883-1A 2002-10-23 2003-10-21 Derivados de piridoindolona substituìdos em -3 por uma fenila, seu preparo e sua aplicação em terapêutica BR0314883A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213264A FR2846329B1 (fr) 2002-10-23 2002-10-23 Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
PCT/FR2003/003110 WO2004041817A1 (fr) 2002-10-23 2003-10-21 Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
BR0314883A true BR0314883A (pt) 2005-08-02

Family

ID=32088223

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314883-1A BR0314883A (pt) 2002-10-23 2003-10-21 Derivados de piridoindolona substituìdos em -3 por uma fenila, seu preparo e sua aplicação em terapêutica

Country Status (32)

Country Link
US (2) US7390818B2 (enExample)
EP (1) EP1556382B1 (enExample)
JP (1) JP4488899B2 (enExample)
KR (1) KR101051859B1 (enExample)
CN (1) CN100345850C (enExample)
AR (1) AR041689A1 (enExample)
AT (1) ATE396994T1 (enExample)
AU (1) AU2003296769B2 (enExample)
BR (1) BR0314883A (enExample)
CA (1) CA2502769C (enExample)
CY (1) CY1109785T1 (enExample)
DE (1) DE60321372D1 (enExample)
DK (1) DK1556382T3 (enExample)
EA (1) EA010833B1 (enExample)
ES (1) ES2304546T3 (enExample)
FR (1) FR2846329B1 (enExample)
HR (1) HRP20050362B1 (enExample)
IL (1) IL168133A (enExample)
IS (1) IS2641B (enExample)
MA (1) MA27455A1 (enExample)
ME (1) ME00102B (enExample)
MX (1) MXPA05004349A (enExample)
NO (1) NO331297B1 (enExample)
NZ (1) NZ539866A (enExample)
PL (1) PL214867B1 (enExample)
PT (1) PT1556382E (enExample)
RS (1) RS51605B (enExample)
SI (1) SI1556382T1 (enExample)
TW (1) TWI325864B (enExample)
UA (1) UA79317C2 (enExample)
WO (1) WO2004041817A1 (enExample)
ZA (1) ZA200503231B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
FR2869316B1 (fr) * 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2876377B1 (fr) * 2004-10-11 2007-03-16 Univ Claude Bernard Lyon Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
JP6072539B2 (ja) 2009-05-27 2017-02-01 アルカーメス ファーマ アイルランド リミテッド ナノ粒子活性物質組成物におけるフレーク状凝集の軽減
FR2945950A1 (fr) 2009-05-27 2010-12-03 Elan Pharma Int Ltd Compositions de nanoparticules anticancereuses et procedes pour les preparer
FR2959133A1 (fr) 2010-04-22 2011-10-28 Sanofi Aventis Formulation pharmaceutique anticancereuse
CN107459481A (zh) * 2017-07-25 2017-12-12 广州大学 一种3‑（4‑甲氧基苯基）‑6‑甲氧基‑4‑氯‑5,7‑二溴喹啉的合成方法
US12122780B2 (en) * 2019-02-01 2024-10-22 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor
CN113329276B (zh) * 2020-02-28 2022-10-28 华为技术有限公司 数据传输方法、装置、网关、芯片及存储介质
CN116171156B (zh) * 2020-07-31 2025-07-04 江苏奥赛康药业有限公司 含嘧啶基团的三并环类化合物的盐型、晶型及其制备方法
US20240132446A1 (en) * 2021-05-26 2024-04-25 Refined Technologies, Inc. Compositions and methods for removal of n-methyl-2-pyrrolidone (nmp) degradation products and other foulants from nmp purification systems

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
ATE386131T1 (de) 1994-04-13 2008-03-15 Univ Rockefeller Aav-vermittelte überbringung von dna in zellen des nervensystems
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
JP2002510686A (ja) 1998-04-02 2002-04-09 ニューロゲン コーポレイション アミノアルキルで置換された５，６，７，８−テトラヒドロ−９Ｈ−ピリジノ［２，３−ｂ］インドール及び５，６，７，８−テトラヒドロ−９Ｈピリミジノ［４，５−Ｂ］インドール誘導体：ＣＲＦ１特異的配位子
IT1313592B1 (it) * 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
KR101051859B1 (ko) 2011-07-25
PT1556382E (pt) 2008-07-09
DK1556382T3 (da) 2008-10-06
RS51605B (sr) 2011-08-31
MEP22208A (en) 2010-06-10
RS20050362A (sr) 2007-11-15
US20080214538A1 (en) 2008-09-04
AU2003296769B2 (en) 2010-02-04
US8012991B2 (en) 2011-09-06
HRP20050362B1 (hr) 2014-01-31
CA2502769A1 (en) 2004-05-21
PL214867B1 (pl) 2013-09-30
AU2003296769A1 (en) 2004-06-07
SI1556382T1 (sl) 2008-10-31
CN100345850C (zh) 2007-10-31
PL376790A1 (pl) 2006-01-09
MA27455A1 (fr) 2005-07-01
UA79317C2 (en) 2007-06-11
TW200413368A (en) 2004-08-01
CA2502769C (en) 2011-03-15
ES2304546T3 (es) 2008-10-16
EP1556382B1 (fr) 2008-05-28
EA200500521A1 (ru) 2005-12-29
ME00102B (me) 2010-10-10
IS2641B (is) 2010-08-15
JP2006511498A (ja) 2006-04-06
CY1109785T1 (el) 2014-09-10
ATE396994T1 (de) 2008-06-15
FR2846329A1 (fr) 2004-04-30
HRP20050362A2 (en) 2005-12-31
WO2004041817A1 (fr) 2004-05-21
US20050288318A1 (en) 2005-12-29
EA010833B1 (ru) 2008-12-30
NO331297B1 (no) 2011-11-21
NZ539866A (en) 2008-01-31
ZA200503231B (en) 2006-06-28
CN1729190A (zh) 2006-02-01
NO20051983D0 (no) 2005-04-22
AR041689A1 (es) 2005-05-26
KR20050086421A (ko) 2005-08-30
JP4488899B2 (ja) 2010-06-23
TWI325864B (en) 2010-06-11
FR2846329B1 (fr) 2004-12-03
MXPA05004349A (es) 2005-08-26
IL168133A (en) 2010-05-31
IS7815A (is) 2005-04-20
DE60321372D1 (de) 2008-07-10
HK1074446A1 (zh) 2005-11-11
EP1556382A1 (fr) 2005-07-27
US7390818B2 (en) 2008-06-24
NO20051983L (no) 2005-07-22

Similar Documents

Publication Publication Date Title
BR0314883A (pt) Derivados de piridoindolona substituìdos em -3 por uma fenila, seu preparo e sua aplicação em terapêutica
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
GT200400092A (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
CR9375A (es) Derivados de ciclopropanocarboxamida
ATE300540T1 (de) Imidazopyridin-derivate
BRPI0508098A (pt) compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
TR200201156T2 (tr) 4-Fenilpiperidin bileşimleri.
BRPI1007456A2 (pt) derivados de azaespiranil-alquilcarbamatos de compostos heterocíclicos com 5 membros, o respectivo preparo e a respectiva aplicação em terapêutica
CR9066A (es) Nuevos derivados de aminopirimidina que tiene accion inhibitoria selectiva de la aurora a
DE60328010D1 (de) Heterocyclische verbindungen
DK1767535T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
NO20076680L (no) Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
DE602007004740D1 (de) Antibiotische spiroderivate
ATE477256T1 (de) Thienylverbindungen
MA32192B1 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
BRPI0411723A (pt) agente redutor de colesterol no soro ou agente preventivo ou terapêutico para aterosclerose, e, método de dosagem de um agente redutor de colesterol no soro ou agente preventivo ou terapêutico para aterosclerose
DE602005027213D1 (de) Neue imidazolidinderivate
DE602004031410D1 (de) Inden derivate als pharmazeutika
ATE409177T1 (de) Synthetische multiple quaternäre ammoniumsalze
NO20062491L (no) Benzoksazinderivter og deres anvendelse
PA8607701A1 (es) Compuestos
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
TW200744589A (en) Pharmaceutical composition
BRPI0601766A (pt) composições contendo aminas e seu uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2328 DE 18-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.